Surviving 34 (68%) N (%), Mean ± SD (median) | Deceased 16 (32%) N (%), Mean ± SD (median) | p value | |
---|---|---|---|
Age | 42.9 ± 9.4 | 50.1 ± 10.4 | 0.018* |
Gender | |||
Male | 20 (58.8%) | 12 (75%) | 0.35 |
Female | 14 (41.2%) | 4 (25%) | |
Clinical findings | |||
GCS | 8.4 ± 2.9 (8) | 5.6 ± 2.4 (4.5) | 0.001* |
Isochoric pupils | 10 (29.45%) | 0 | 0.02* |
Risk factors | |||
DM | 4 (11.8%) | 5 (31.3%) | 0.09 |
Cardiac | 6 (17.7%) | 0 | 0.07 |
Hypertension | 16 (47%) | 6 (37.5%) | 0.5 |
Previous treatment | 8 (23.5%) | 0 | 0.03* |
Radiological findings | |||
Contralateral ventriculomegaly | 12 (35.3%) | 2 (12.5%) | 0.09 |
Midline shift | 8.3 ± 3.4 | 10 ± 3.3 | 0.09 |
Hemorrhagic infarction | 2 (5.9%) | 2 (12.5%) | 0.5 |
Left side | 24 (70.6%) | 12 (75%) | 0.7 |
Treatment | |||
Early surgery | 10 (62.5%) | 6 (37.5%) | 0.7 |
Delayed surgery | 24 (70.6%) | 10 (29.4%) | |
Time of deterioration (days) | 3.4 ± 2.6 (3) | 2.6 ± 1.6 (2.5) | 0.25 |
Time lapse between deterioration and surgery time (h) | 6.4 ± 3.7 | 14.6 ± 9.4 | 0.0001* |